Khalid Mohammed Khand (Khalid M Khan, Khalid Mohammed Khan)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 45

Top Venues

Future medicinal chemistry

ACS omega

Archiv der Pharmazie

Pharmaceutical patent analyst

University of Karachi and Imam AbdulRahman Bin Faisal University

University of Karachi HEJ Research Institute of Chemistry (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Karachi and Imam AbdulRahman Bin Faisal University Sep 12 1997

Pakistan

Professor :: H. E. J. Research Institutute of Chemistry

Education History

University of Karachi HEJ Research Institute of Chemistry

Pakistan

PHD :: HEJ Research Institute of Chemistry

Publications

Bilquees Bano, null Kanwal, Shehryar Hameed, Mehreen Lateef, Abdul Wadood, Sulaiman Shams, Shafqat Hussain, Noor Ui Ain, Shahnaz Perveen, Muhammad Taha, Khalid Mohammed Khand
Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors. Future medicinal chemistry 16 (6) (2024)
Maryam Maqbool, Mehwish Solangi, Khalid Mohammed Khand, Musa Özil, Nimet Baltaş, Uzma Salar, Syeda S Tariq, Zaheer Ul Haq, Muhammad Taha
Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies. Archiv der Pharmazie 357 (9) (2024)
Bilquees Bano, null Kanwal, Shehryar Hameed, Mehreen Lateef, Abdul Wadood, Sulaiman Shams, Shafqat Hussain, Noor Ui Ain, Shahnaz Perveen, Muhammad Taha, Khalid Mohammed Khand
Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors. Future medicinal chemistry 16 (6) (2024)
Bilquees Bano, null Kanwal, Shehryar Hameed, Mehreen Lateef, Abdul Wadood, Sulaiman Shams, Shafqat Hussain, Noor Ui Ain, Shahnaz Perveen, Muhammad Taha, Khalid Mohammed Khand
Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors. Future medicinal chemistry (2024)
Bilquees Bano, null Kanwal, Shehryar Hameed, Mehreen Lateef, Abdul Wadood, Sulaiman Shams, Shafqat Hussain, Noor Ui Ain, Shahnaz Perveen, Muhammad Taha, Khalid Mohammed Khand
Unsymmetrical thiourea derivatives: synthesis and evaluation as promising antioxidant and enzyme inhibitors. Future medicinal chemistry 16 (6) (2024)
Maryam Maqbool, Mehwish Solangi, Khalid Mohammed Khand, Musa Özil, Nimet Baltaş, Uzma Salar, Syeda S Tariq, Zaheer Ul Haq, Muhammad Taha
Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies. Archiv der Pharmazie (2024)
Irfan Ali, Rafaila Rafique, Khalid Mohammed Khand, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Uzma Salar, Suliman A Almahmoud, Ashfaq Ur Rehman, Shatha Ghazi Felemban, Shehryar Hameed, Shahnaz Perveen
Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus. Future medicinal chemistry 15 (2) (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry 15 (6) (2023)
Shahbaz Shamim, Khalid Mohammed Khand, Muhammad Ali, Mohammad Mahdavi, Uzma Salar, Maryam Mohammadi-Khanaposhtani, Mohammad Ali Faramarzi, Nisar Ullah, Muhammad Taha
Diphenyl-substituted triazine derivatives: synthesis, α-glucosidase inhibitory activity, kinetics and in silico studies. Future medicinal chemistry (2023)
Irfan Ali, Rafaila Rafique, Khalid Mohammed Khand, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Uzma Salar, Suliman A Almahmoud, Ashfaq Ur Rehman, Shatha Ghazi Felemban, Shehryar Hameed, Shahnaz Perveen
Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus. Future medicinal chemistry 15 (2) (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Faiza Saleem, Fouzia Naz, Khalid Mohammed Khand
Patent analysis of novel therapeutic approaches for treating Alzheimer's disease 2018-2023. Pharmaceutical patent analyst (2023)
Irfan Ali, Rafaila Rafique, Khalid Mohammed Khand, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Uzma Salar, Suliman A Almahmoud, Ashfaq Ur Rehman, Shatha Ghazi Felemban, Shehryar Hameed, Shahnaz Perveen
Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus. Future medicinal chemistry (2023)
Faiza Saleem, Fariha Shamim, Musa Özil, Nimet Baltaş, Uzma Salar, Sajda Ashraf, Zaheer Ul Haq, Muhammad Taha, Mehwish Solangi, Khalid Mohammed Khand
Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors. Future medicinal chemistry (2023)
Muhammad Taha, Fazal Rahim, Shawkat Hayat, Sridevi Chigurupati, Khalid Mohammed Khand, Syahrul Imran Abu Bakar, Syed Adnan Ali Shah, Nizam Uddin, Shatha Ghazi Felemban, Vijayan Venugopal
New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and in silico study. Future medicinal chemistry (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry 15 (6) (2023)
Irfan Ali, Rafaila Rafique, Khalid Mohammed Khand, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Uzma Salar, Suliman A Almahmoud, Ashfaq Ur Rehman, Shatha Ghazi Felemban, Shehryar Hameed, Shahnaz Perveen
Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus. Future medicinal chemistry 15 (2) (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Irfan Ali, Rafaila Rafique, Khalid Mohammed Khand, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Uzma Salar, Suliman A Almahmoud, Ashfaq Ur Rehman, Shatha Ghazi Felemban, Shehryar Hameed, Shahnaz Perveen
Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus. Future medicinal chemistry 15 (2) (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry 15 (6) (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry 15 (6) (2023)
Faiza Seraj, Khalid Mohammed Khand, Jamshed Iqbal, Aqeel Imran, Zahid Hussain, Uzma Salar, Shehryar Hameed, Muhammad Taha
Evaluation of synthetic aminoquinoline derivatives as urease inhibitors: in vitro , in silico and kinetic studies. Future medicinal chemistry (2023)
Bibi Fatima, Faiza Saleem, Uzma Salar, Sridevi Chigurupati, Shatha G Felemban, Zaheer Ul-Haq, Syeda S Tariq, Suliman A Almahmoud, Muhammad Taha, Syed T A Shah, Khalid Mohammed Khand
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies. Archiv der Pharmazie (2023)
Israr Ul Haq, Irfan Ali, Uzma Salar, Sridevi Chigurupati, Urooj Qureshi, Suliman A Almahmoud, Shehryar Hameed, Sreenadh Konanki, Manzoor Ahmad, Mohsin Ali, Zaheer Ul Haq, Khalid Mohammed Khand
Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities. Future medicinal chemistry (2023)
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khand, Sridevi Chigurupati, Ifeanyi Edozie Otuokere, Francis Kalu Ekuma, Uzma Salar, Shatha Ghazi Felemban, Ashfaq Ur Rehman, Abdul Wadood, Muhammad Taha
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents. Future medicinal chemistry 15 (1) (2023)
Mehwish Solangi, Khalid Mohammed Khand, Xingyue Ji, Musa Özil, Nimet Baltaş, Uzma Salar, Alamgir Khan, Zaheer Ul Haq, Herchand Meghwar, Muhammad Taha
Indole-pyridine carbonitriles: multicomponent reaction synthesis and bio-evaluation as potential hits against diabetes mellitus. Future medicinal chemistry (2023)
Faiza Saleem, Khalid Mohammed Khand, Nisar Ullah, Musa Özil, Nimet Baltaş, Shehryar Hameed, Uzma Salar, Abdul Wadood, Ashfaq Ur Rehman, Mukesh Kumar, Muhammad Taha, Syed Moazzam Haider
Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants. Archiv der Pharmazie (2022)
Sajjad Ahmad, Momin Khan, Muhammad Ishaq Ali Shah, Mahboob Ali, Aftab Alam, Muhammad Riaz, Khalid Mohammed Khand
Synthetic Transformation of 2-{2-Fluoro[1,1'-biphenyl]-4-yl} Propanoic Acid into Hydrazide-Hydrazone Derivatives: In Vitro Urease Inhibition and In Silico Study. ACS omega 7 (49) (2022)
Mohammad Assad, Zahida Parveen, Saira Farman, Beenish Khurshid, Muhammad Ali Hashmi, Khalid Mohammed Khand, Akif Khurshid
In Vitro Screening and MD Simulations of Thiourea Derivatives against SARS-CoV-2 in Association with Multidrug Resistance ABCB1 Transporter. ACS omega 7 (51) (2022)
Ayaz Ahmed, Anum Khalid Khan, Aneela Karim, Rakhshinda Siddiqui, Rafaila Rafique, Syed Abid Ali, Mehwish Solangi, Muhammad Taha, Khalid Mohammed Khand
Enoxacin-based derivatives: antimicrobial and antibiofilm agent: a biology-oriented drug synthesis (BIODS) approach. Future medicinal chemistry 14 (13) (2022)
Maham Haider, Khalid Mohammed Khand
Patent developments via Schiff bases in medicinal chemistry. Pharmaceutical patent analyst (2022)
Shehryar Hameed, Oluwatoyin Babatunde, Uzma Salar, Abdul Jabbar, Sridevi Chigurupati, Mehwish Solangi, Lubna Atta, Zaheer Ul Haq, Faiza Saleem, Saurabh Bhatia, Ahmed Al-Harrasi, Muhammad Taha, Khalid Mohammed Khand
Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer's disease. Future medicinal chemistry 14 (21) (2022)
Samuel Attah Egu, Irfan Ali, Khalid Mohammed Khand, Sridevi Chigurupati, Urooj Qureshi, Uzma Salar, Muhammad Taha, Shatha Ghazi Felemban, Vijayan Venugopal, Zaheer Ul-Haq
Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers. Molecular diversity (2022)
Mohammad Assad, Zahida Parveen, Saira Farman, Beenish Khurshid, Muhammad Ali Hashmi, Khalid Mohammed Khand, Akif Khurshid
In Vitro Screening and MD Simulations of Thiourea Derivatives against SARS-CoV-2 in Association with Multidrug Resistance ABCB1 Transporter. ACS omega 7 (51) (2022)
Sajjad Ahmad, Momin Khan, Muhammad Ishaq Ali Shah, Mahboob Ali, Aftab Alam, Muhammad Riaz, Khalid Mohammed Khand
Synthetic Transformation of 2-{2-Fluoro[1,1'-biphenyl]-4-yl} Propanoic Acid into Hydrazide-Hydrazone Derivatives: In Vitro Urease Inhibition and In Silico Study. ACS omega 7 (49) (2022)
Mehwish Solangi, null Kanwal, Khalid Mohammed Khand, Sridevi Chigurupati, Faiza Saleem, Urooj Qureshi, Zaheer Ul-Haq, Almas Jabeen, Shatha G Felemban, Fatima Zafar, Shahnaz Perveen, Muhammad Taha, Saurabh Bhatia
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies. Archiv der Pharmazie 355 (6) (2022)
Oluwatoyin Babatunde, Shehryar Hameed, Uzma Salar, Sridevi Chigurupati, Abdul Wadood, Ashfaq Ur Rehman, Vijayan Venugopal, Khalid Mohammed Khand, Muhammad Taha, Shahnaz Perveen
Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management. Molecular diversity (2021)
Akinsola Adegboye Akande, Uzma Salar, Khalid Mohammed Khand, Shazia Syed, Sherifat Adeyinka Aboaba, Sridevi Chigurupati, Abdul Wadood, Muhammad Riaz, Muhammad Taha, Saurabh Bhatia, null Kanwal, Shahbaz Shamim, Shahnaz Perveen
Substituted Benzimidazole Analogues as Potential α-Amylase Inhibitors and Radical Scavengers. ACS omega 6 (35) (2021)
Fayaz Ali, Shahbaz Shamim, Mehreen Lateef, Khalid Mohammed Khand, Muhammad Taha, Uzma Salar, Abdul Wadood, Ashfaq Ur Rehman, Noor Ul Ain Nawaz, Shahnaz Perveen
N-Aryl-3,4-dihydroisoquinoline Carbothioamide Analogues as Potential Urease Inhibitors. ACS omega 6 (24) (2021)
null Kanwal, Khalid Mohammed Khand, Sridevi Chigurupati, Farman Ali, Munisaa Younus, Maha Aldubayan, Abdul Wadood, Huma Khan, Muhammad Taha, Shahnaz Perveen
Correction to "Indole-3-acetamides: As Potential Antihyperglycemic and Antioxidant Agents; Synthesis, In Vitro α -Amylase Inhibitory Activity, Structure-Activity Relationship, and In Silico Studies". ACS omega 7 (1) (2021)
Ibanga Okon Isaac, Iqra Munir, Mariya Al-Rashida, Syed Abid Ali, Zahid Shafiq, Muhammad Islam, Ralf Ludwig, Khurshid Ayub, Khalid Mohammed Khand, Abdul Hameed
Novel acridine-based thiosemicarbazones as 'turn-on' chemosensors for selective recognition of fluoride anion: a spectroscopic and theoretical study. Royal Society open science 5 (7) (2018)
null null, Faiza Ahad, Nida Ghouri, null null, Khalid Mohammed Khand, Shahnaz Perveen, M Iqbal Choudhary
Synthesis of 4-substituted ethers of benzophenone and their antileishmanial activities. Royal Society open science 5 (5) (2018)

Khalid Mohammed Khand.css-eqlu8i{font-size:small;padding-left:4px;} (Khalid M Khan, Khalid Mohammed Khan)

Publication Activity (10 Years)

Top Topics

Top Venues

Khalid Mohammed Khand (Khalid M Khan, Khalid Mohammed Khan)